Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2062328
Max Phase: Preclinical
Molecular Formula: C43H50F5N3O8
Molecular Weight: 681.79
Molecule Type: Small molecule
Associated Items:
ID: ALA2062328
Max Phase: Preclinical
Molecular Formula: C43H50F5N3O8
Molecular Weight: 681.79
Molecule Type: Small molecule
Associated Items:
Synonyms (2): TCMDC-141339 | TCMDC-141339
Synonyms from Alternative Forms(2):
Canonical SMILES: CCN1CCC(N(CCCCCCc2ccc(C(F)(F)F)cc2)C(=O)Cn2c(CCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1.O=C(O)C(O)C(O)C(=O)O
Standard InChI: InChI=1S/C39H44F5N3O2.C4H6O6/c1-2-45-24-21-31(22-25-45)46(23-8-4-3-5-10-28-15-18-30(19-16-28)39(42,43)44)37(49)27-47-32(20-17-29-11-9-13-34(40)38(29)41)26-36(48)33-12-6-7-14-35(33)47;5-1(3(7)8)2(6)4(9)10/h6-7,9,11-16,18-19,26,31H,2-5,8,10,17,20-25,27H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)
Standard InChI Key: RZQSVBIBWVPKFG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 681.79 | Molecular Weight (Monoisotopic): 681.3354 | AlogP: 8.20 | #Rotatable Bonds: 14 |
Polar Surface Area: 45.55 | Molecular Species: BASE | HBA: 4 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 8.71 | CX LogP: 8.55 | CX LogD: 7.22 |
Aromatic Rings: 4 | Heavy Atoms: 49 | QED Weighted: 0.10 | Np Likeness Score: -1.13 |
1. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF.. (2010) Thousands of chemical starting points for antimalarial lead identification., 465 (7296): [PMID:20485427] [10.1038/nature09107] |
2. St. Jude Leishmania screening dataset., [10.6019/CHEMBL3433997] |
Source(2):